ArticleTropical medicine and infectious disease2022

The Effectiveness of the Use of Regdanvimab (CT-P59) in Addition to Remdesivir in Patients with Severe COVID-19: A Single Center Retrospective Study.

Ganghee Chae et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.